Session 1
Chairpersons主持：
ZHU Wenling 朱文铃 GUO Jingxuan 郭静萱
08:00-08:50
To Improve Prevention and Treatment for Thrombotic
Disease in New Century
应对世纪的挑战，做好血栓性疾病的防治
HU Dayi 胡大一
08:50-09:40
Mechanism and Treatment Strategy of Thrombosis
in
Artery System
动脉系统血栓发生机制及干预靶点
PAN Jiaqi 潘家琦
09:40-10:10
Break & Exhibition 休息与观展
10:10-11:00
Thrombolylitic Therapy for Acute Myocardial
Infarction
急性心肌梗死溶栓辅助抗凝治疗进展
ZHU Wenling 朱文玲
11:00-11:50
Anticoagulation Theraputic strategy in NSTE
ACS From Ⅶ ACCP
从最新指南看NSTE ACS 的抗凝治疗策略
GUO Jingxuan郭静萱
11:50-12:00
Panel Discussion讨论 |
Session 2
Chairpersons主持：
GAO Runlin高润霖 PAN Jiaqi潘家琦
13:00-13:40
Clinic Experience with Optimal In Vena Cava
Filters
腔静脉滤器的临床经验
Fabrice-Guy Barral France
13:40-14:20
From Vulnerable Plaques, Vulnerable Blood to
Vulnerable Patients
从易损斑块、易损血液到易损病人
GAO Runlin 高润霖
14:20-15:00
Evolution from Heparin to Low Molecular Weight
Heparin
从最新研究进展看低分子肝素与肝素的区别
CHEN Jiyan 陈纪言
15:00-15:30
Break & Exhibition 休息与观展
15:30-16:10
Can LMWH Replace UFH in PCI?
介入治疗低分子肝素能取代普通肝素吗?
JIA Sanqing 贾三庆
16:10-16:40
Anticoagulation Therapy of Atrial Fibrillation
房颤的抗凝治疗
SUN Yihong 孙艺红
16:40-17:00
Panel Discussion 讨论 |
